The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal … Read more “AQS3pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019”
Our team recently joined international bioprocess professionals at the Bioprocessing Summit, where we discussed practical solutions for bioprocess challenges. Karan Shah, Principal Development Associate, Analytical … Read more “Immunogen presents MMS data in talk at Bioprocessing Summit”
The RedShiftBio team has just returned from Colorado where we attended a great workshop on aggregation and immunogenicity. Aggregation of therapeutic proteins can occur during … Read more “Workshop on Protein Aggregation and Immunogenicity in Colorado”
PEGS: The Essential Protein Engineering Summit is one of the industry’s most preeminent events that inspires accelerated biotherapeutic protein drug development. Over 2,300 international participants … Read more “RedShiftBio Stole the Show at PEGS with the Launch of AQS3™pro”
The 7th International Symposium on Higher Order Structure (HOS) of Protein Therapeutics focused on biophysical methods for assessment of HOS, as well as the tools … Read more “RedShiftBio presents MMS data at HOS 2018”
BPS18 was the 62nd annual meeting for the Biophysical Society, one of the largest gathering of biophysicists in the world. There were more than 7,000 … Read more “Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization”
RedShift™, RedShiftBio®, See Change®, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.